2021
DOI: 10.1016/j.jconrel.2021.08.016
|View full text |Cite
|
Sign up to set email alerts
|

Influence of lipid matrix composition on biopharmaceutical properties of lipid nanoparticles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
8
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 23 publications
(10 citation statements)
references
References 32 publications
1
8
0
1
Order By: Relevance
“…6A). The decrease in corneometer values for the NLC confirms the formation of the invisible patch, that was previously reported for various other NLC formulations [1,2,39,40]. Six hour after application, no significant differences in skin hydration were found between oil, ME, and NE.…”
Section: Skin Hydrationsupporting
confidence: 87%
See 1 more Smart Citation
“…6A). The decrease in corneometer values for the NLC confirms the formation of the invisible patch, that was previously reported for various other NLC formulations [1,2,39,40]. Six hour after application, no significant differences in skin hydration were found between oil, ME, and NE.…”
Section: Skin Hydrationsupporting
confidence: 87%
“…Dry skin will therefore result in poor penetration. Therefore, only long-lasting, durable films can provide an effective and long-lasting dermal penetration [37,[39][40][41]. Data of this study show that after dermal application of the different formulations, the NLC provided the best protection from chemical degradation for the AI surrogate and resulted in the most effective and durable film on top of the skin.…”
Section: Synopsis Of Biopharmaceutical Propertiesmentioning
confidence: 79%
“…Most liposomes/LNPs are undoubtedly used in medical science, but academics who usually use these nanoparticles for drug delivery prefer conventional bulk methods, such as ethanol dilution, solvent injection or homogenization to prepare liposomes. 19 , 175 , 176 They concentrate on designing and optimizing the nanocarrier itself instead of novel techniques for nanocarrier preparation. Since the production techniques cannot resolve the critical clinical problems in liposomal applications, such as delivery efficacy, organ-specific and cell-specific delivery and toxicity, to mention a few, it was not surprising that these bulk methods were chosen due to simplicity, cost-saving and safety.…”
Section: Discussionmentioning
confidence: 99%
“…The NLC are a well-known drug delivery system with superior properties on skin [ 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 ]. In this study, they were produced after a previously established production protocol [ 25 ].…”
Section: Methodsmentioning
confidence: 99%